Delivery Order SPE2DB24D2106-SPE2DB24FAUDF
Award Date 4/23/24
Potential Completion Date 4/24/24
Potential Value $8.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) on July 16, 2024. The $2,104.02 fixed-price contract is for the delivery of an Advair HFA 230-21 MCG inhaler product. The order is part of the DLA's Medical Supply Chain division and is issued under a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group to provide a comprehensive range of pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,952.07 order is for 4,565,007,305 units of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is valued at $2,638.06 and runs through March 22, 2024. It is not designated as a set-aside contract. The contract is for the delivery of Advair HFA 45-21 MCG inhalers, a pharmaceutical product. This award is likely part of a larger indefinite delivery vehicle (IDV) contract between DMS Pharmaceutical Group and DLA, valued...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,082.72 contract is for the supply of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under...
- The Defense Logistics Agency awarded a $4,922.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, for the supply of Advair HFA 230-21 microgram inhalers (12 gram units). The contract, which carries an ultimate completion date of August 1, 2025, represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. No set-aside designation was applied to this...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,385.11 contract is for the delivery of 4565520224 ADVAIR HFA 230-21 MCG INHALER 12GM, with a completion date of August 21, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to the Department...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, with a ceiling value of $1,242.48 and a completion date of May 21, 2024. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. valued at up to $499,999,999, which allows the DLA to issue...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of Advair HFA 115-21 MCG Inhaler 12GM. The $4,157.10 contract has a completion date of June 6, 2024 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, valued at...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $13,743.12, is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM medical supplies. The contract has no set-aside designation and is a firm fixed-price delivery order with an ultimate completion date of September 26, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,562.04 for the supply of pharmaceutical products, including Advair HFA 115-21 MCG inhalers. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is part of the SPE2DB indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a...